个人中心 - 老虎社区

dahae

IP属地：未知

帖子 · 302帖子 · 302
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- dahaedahae
  ·2022-01-16
  Q
  非常抱歉，此主贴已删除
  1,915 1
  点赞
  分享
  举报
- dahaedahae
  ·2022-01-15
  Q
  非常抱歉，此主贴已删除
  1,373 1
  2
  分享
  举报
- dahaedahae
  ·2022-01-15
  Qqqq
  非常抱歉，此主贴已删除
  1,165 1
  1
  分享
  举报
- dahaedahae
  ·2022-01-14
  Qqq
  10 Biggest Price Target Changes For Friday
  Keybanc cut Robinhood Markets, Inc. price target from $50 to $25. Robinhood shares fell 0.1% to $15.
  10 Biggest Price Target Changes For Friday
  987 1
  1
  分享
  举报
- dahaedahae
  ·2022-01-13
  Qqqq
  Biogen says yet to speak with CMS about coverage of Alzheimer's drug
  (Reuters) - Biogen Inc has not discussed with the Centers for Medicaid and Medicare Services about i
  Biogen says yet to speak with CMS about coverage of Alzheimer's drug
  1,455 1
  1
  分享
  举报
- dahaedahae
  ·2022-01-13
  Qqq
  Aesthetics Firm Suneva Is in Talks for Viveon Health SPAC Deal
  (Bloomberg) -- Suneva Medical Inc., which sells beauty and anti-aging products to doctors’ offices,
  Aesthetics Firm Suneva Is in Talks for Viveon Health SPAC Deal
  1,314 1
  点赞
  分享
  举报
- dahaedahae
  ·2022-01-11
  Qqwq
  7 Hot Stocks to Buy on Any Dip This Year
  An increase in interest rates is looming due to higher inflation, supply-chain issues, lofty stock v
  7 Hot Stocks to Buy on Any Dip This Year
  1,093 1
  点赞
  分享
  举报
- dahaedahae
  ·2022-01-10
  Qqqqq
  Is Tesla Stock Headed to $1,400 or $67? Why Predicting Auto Makers’ Performance Is Tricky
  Who needs parody cryptocurrency when car stocks are this exciting?
  Is Tesla Stock Headed to $1,400 or $67? Why Predicting Auto Makers’ Performance Is Tricky
  1,711 4
  6
  分享
  举报
- dahaedahae
  ·2022-01-10
  Qqqq
  The Year’s First Three IPOs All Struggled. This Is Why.
  The first initial public offerings of 2022, a trio of biotech companies, went public with dismal res
  The Year’s First Three IPOs All Struggled. This Is Why.
  1,238 1
  点赞
  分享
  举报
- dahaedahae
  ·2022-01-08
  Qqq
  非常抱歉，此主贴已删除
  1,064 1
  1
  分享
  举报

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3560092322694803","uuid":"3560092322694803","gmtCreate":1597135194870,"gmtModify":1614044926890,"name":"dahae","pinyin":"dahae","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/137beae1f6048901843924ba46796740","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":13,"headSize":161,"tweetSize":302,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":2,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.03.23","exceedPercentage":"60.84%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.53%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.25","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":697377494,"gmtCreate":1642326902440,"gmtModify":1642326902648,"author":{"id":"3560092322694803","authorId":"3560092322694803","name":"dahae","avatar":"https://static.tigerbbs.com/137beae1f6048901843924ba46796740","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560092322694803","authorIdStr":"3560092322694803"},"themes":[],"htmlText":"Q","listText":"Q","text":"Q","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/697377494","repostId":"1169852230","repostType":4,"isVote":1,"tweetType":1,"viewCount":1915,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":697943099,"gmtCreate":1642236922912,"gmtModify":1642236923082,"author":{"id":"3560092322694803","authorId":"3560092322694803","name":"dahae","avatar":"https://static.tigerbbs.com/137beae1f6048901843924ba46796740","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560092322694803","authorIdStr":"3560092322694803"},"themes":[],"htmlText":"Q","listText":"Q","text":"Q","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/697943099","repostId":"2203198710","repostType":4,"isVote":1,"tweetType":1,"viewCount":1373,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":697949554,"gmtCreate":1642236866890,"gmtModify":1642236867086,"author":{"id":"3560092322694803","authorId":"3560092322694803","name":"dahae","avatar":"https://static.tigerbbs.com/137beae1f6048901843924ba46796740","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560092322694803","authorIdStr":"3560092322694803"},"themes":[],"htmlText":"Qqqq","listText":"Qqqq","text":"Qqqq","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/697949554","repostId":"2203198710","repostType":4,"isVote":1,"tweetType":1,"viewCount":1165,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":697066627,"gmtCreate":1642166898668,"gmtModify":1642167319572,"author":{"id":"3560092322694803","authorId":"3560092322694803","name":"dahae","avatar":"https://static.tigerbbs.com/137beae1f6048901843924ba46796740","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560092322694803","authorIdStr":"3560092322694803"},"themes":[],"htmlText":"Qqq","listText":"Qqq","text":"Qqq","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/697066627","repostId":"1159268879","repostType":4,"repost":{"id":"1159268879","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1642163579,"share":"https://www.laohunote.com/m/news/1159268879?lang=&edition=full","pubTime":"2022-01-14 20:32","market":"us","language":"en","title":"10 Biggest Price Target Changes For Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1159268879","media":"Benzinga","summary":"Keybanc cut Robinhood Markets, Inc. price target from $50 to $25. Robinhood shares fell 0.1% to $15.","content":"<html><head></head><body><ul><li>Keybanc cut <b>Robinhood Markets, Inc.</b> price target from $50 to $25. Robinhood shares fell 0.1% to $15.28 in pre-market trading.</li><li>SVB Leerink boosted <b>Amicus Therapeutics, Inc.</b> price target from $12 to $16. Amicus Therapeutics shares rose 3.9% to $10.30 in pre-market trading.</li><li>JP Morgan raised the price target for <b>O&#39;Reilly Automotive, Inc.</b> from $695 to $785. O&#39;Reilly Automotive shares rose 1.4% to $697.15 in pre-market trading.</li><li>BMO Capital raised <b>The Mosaic Company</b> price target from $37 to $50. Mosaic shares rose 2.8% to $42.79 in pre-market trading.</li><li>RBC Capital lifted <b>Ford Motor Company</b> price target from $21 to $26. Ford shares fell 1.7% to $24.60 in pre-market trading.</li><li>Keybanc reduced the price target on <b>Zoom Video Communications, Inc.</b> from $344 to $253. Zoom Video shares fell 0.3% to $161.61 in pre-market trading.</li><li>Raymond James raised the price target for <b>KB Home</b> from $55 to $63. KB Home shares fell 0.4% to $49.20 in pre-market trading.</li><li>Keybanc reduced the price target on <b>PayPal Holdings, Inc.</b> from $325 to $250. PayPal shares fell 0.1% to $180.82 in pre-market trading.</li><li>Morgan Stanley cut <b>Domino&#39;s Pizza, Inc.</b> price target from $541 to $535. Domino&#39;s shares dropped 1.3% to $475.00 in pre-market trading.</li><li>JMP Securities boosted the price target on <b>Chubb Limited</b> from $210 to $225. Chubb shares rose 0.3% to $198.20 in pre-market trading.</li></ul></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>10 Biggest Price Target Changes For Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n10 Biggest Price Target Changes For Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2022-01-14 20:32</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><ul><li>Keybanc cut <b>Robinhood Markets, Inc.</b> price target from $50 to $25. Robinhood shares fell 0.1% to $15.28 in pre-market trading.</li><li>SVB Leerink boosted <b>Amicus Therapeutics, Inc.</b> price target from $12 to $16. Amicus Therapeutics shares rose 3.9% to $10.30 in pre-market trading.</li><li>JP Morgan raised the price target for <b>O&#39;Reilly Automotive, Inc.</b> from $695 to $785. O&#39;Reilly Automotive shares rose 1.4% to $697.15 in pre-market trading.</li><li>BMO Capital raised <b>The Mosaic Company</b> price target from $37 to $50. Mosaic shares rose 2.8% to $42.79 in pre-market trading.</li><li>RBC Capital lifted <b>Ford Motor Company</b> price target from $21 to $26. Ford shares fell 1.7% to $24.60 in pre-market trading.</li><li>Keybanc reduced the price target on <b>Zoom Video Communications, Inc.</b> from $344 to $253. Zoom Video shares fell 0.3% to $161.61 in pre-market trading.</li><li>Raymond James raised the price target for <b>KB Home</b> from $55 to $63. KB Home shares fell 0.4% to $49.20 in pre-market trading.</li><li>Keybanc reduced the price target on <b>PayPal Holdings, Inc.</b> from $325 to $250. PayPal shares fell 0.1% to $180.82 in pre-market trading.</li><li>Morgan Stanley cut <b>Domino&#39;s Pizza, Inc.</b> price target from $541 to $535. Domino&#39;s shares dropped 1.3% to $475.00 in pre-market trading.</li><li>JMP Securities boosted the price target on <b>Chubb Limited</b> from $210 to $225. Chubb shares rose 0.3% to $198.20 in pre-market trading.</li></ul></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CB":"安达保险","FOLD":"爱美医疗","KBH":"KB Home","ORLY":"奥莱利","ZM":"Zoom","HOOD":"Robinhood","PYPL":"PayPal","DPZ":"达美乐比萨","F":"福特汽车","MOS":"美国美盛"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159268879","content_text":"Keybanc cut Robinhood Markets, Inc. price target from $50 to $25. Robinhood shares fell 0.1% to $15.28 in pre-market trading.SVB Leerink boosted Amicus Therapeutics, Inc. price target from $12 to $16. Amicus Therapeutics shares rose 3.9% to $10.30 in pre-market trading.JP Morgan raised the price target for O'Reilly Automotive, Inc. from $695 to $785. O'Reilly Automotive shares rose 1.4% to $697.15 in pre-market trading.BMO Capital raised The Mosaic Company price target from $37 to $50. Mosaic shares rose 2.8% to $42.79 in pre-market trading.RBC Capital lifted Ford Motor Company price target from $21 to $26. Ford shares fell 1.7% to $24.60 in pre-market trading.Keybanc reduced the price target on Zoom Video Communications, Inc. from $344 to $253. Zoom Video shares fell 0.3% to $161.61 in pre-market trading.Raymond James raised the price target for KB Home from $55 to $63. KB Home shares fell 0.4% to $49.20 in pre-market trading.Keybanc reduced the price target on PayPal Holdings, Inc. from $325 to $250. PayPal shares fell 0.1% to $180.82 in pre-market trading.Morgan Stanley cut Domino's Pizza, Inc. price target from $541 to $535. Domino's shares dropped 1.3% to $475.00 in pre-market trading.JMP Securities boosted the price target on Chubb Limited from $210 to $225. Chubb shares rose 0.3% to $198.20 in pre-market trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":987,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":694428999,"gmtCreate":1642084303985,"gmtModify":1642084304152,"author":{"id":"3560092322694803","authorId":"3560092322694803","name":"dahae","avatar":"https://static.tigerbbs.com/137beae1f6048901843924ba46796740","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560092322694803","authorIdStr":"3560092322694803"},"themes":[],"htmlText":"Qqqq","listText":"Qqqq","text":"Qqqq","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/694428999","repostId":"2203976407","repostType":4,"repost":{"id":"2203976407","kind":"highlight","pubTimestamp":1642082123,"share":"https://www.laohunote.com/m/news/2203976407?lang=&edition=full","pubTime":"2022-01-13 21:55","market":"us","language":"en","title":"Biogen says yet to speak with CMS about coverage of Alzheimer's drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2203976407","media":"Reuters","summary":"(Reuters) - Biogen Inc has not discussed with the Centers for Medicaid and Medicare Services about i","content":"<html><head></head><body><p>(Reuters) - Biogen Inc has not discussed with the Centers for Medicaid and Medicare Services about its decision on the coverage of the drugmaker&#39;s Alzheimer&#39;s drug, the company&#39;s chief executive officer said in a call with the analyst.</p><p>In a draft decision on Tuesday, CMS, which runs the government health plan for people over age 65, said it would cover Aduhelm, and similar treatments, only for patients enrolled in approved clinical trials.</p><p>&#34;We want to be constructive with CMS. We want just to have a dialogue,&#34; Biogen CEO Michel Vounatsos said.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biogen says yet to speak with CMS about coverage of Alzheimer's drug</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiogen says yet to speak with CMS about coverage of Alzheimer's drug\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-13 21:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Reuters) - Biogen Inc has not discussed with the Centers for Medicaid and Medicare Services about its decision on the coverage of the drugmaker's Alzheimer's drug, the company's chief executive ...</p>\n\n<a href=\"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4533":"AQR资本管理(全球第二大对冲基金)","BIIB":"渤健公司","CMS":"CMS能源","BK4208":"复合型公用事业","BK4532":"文艺复兴科技持仓","BK4139":"生物科技"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2203976407","content_text":"(Reuters) - Biogen Inc has not discussed with the Centers for Medicaid and Medicare Services about its decision on the coverage of the drugmaker's Alzheimer's drug, the company's chief executive officer said in a call with the analyst.In a draft decision on Tuesday, CMS, which runs the government health plan for people over age 65, said it would cover Aduhelm, and similar treatments, only for patients enrolled in approved clinical trials.\"We want to be constructive with CMS. We want just to have a dialogue,\" Biogen CEO Michel Vounatsos said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1455,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":694257889,"gmtCreate":1642003502104,"gmtModify":1642003502285,"author":{"id":"3560092322694803","authorId":"3560092322694803","name":"dahae","avatar":"https://static.tigerbbs.com/137beae1f6048901843924ba46796740","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560092322694803","authorIdStr":"3560092322694803"},"themes":[],"htmlText":"Qqq","listText":"Qqq","text":"Qqq","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/694257889","repostId":"1199219279","repostType":4,"repost":{"id":"1199219279","kind":"news","pubTimestamp":1641998773,"share":"https://www.laohunote.com/m/news/1199219279?lang=&edition=full","pubTime":"2022-01-12 22:46","market":"us","language":"en","title":"Aesthetics Firm Suneva Is in Talks for Viveon Health SPAC Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=1199219279","media":"Bloomberg","summary":"(Bloomberg) -- Suneva Medical Inc., which sells beauty and anti-aging products to doctors’ offices, ","content":"<html><head></head><body><p>(Bloomberg) -- Suneva Medical Inc., which sells beauty and anti-aging products to doctors’ offices, has agreed to go public through a merger with blank-check company Viveon Health Acquisition Corp.</p><p>The deal values the combined company at about $511 million including debt, according to a statement Wednesday that confirmed an earlier Bloomberg News report. Existing Suneva backers will invest $10 million in a private investment in public equity deal, according to Chief Executive Officer Pat Altavilla.</p><p>The combined company will operate as Suneva Medical and trade on the New York Stock Exchange under the symbol RNEW, according to the statement.</p><p>“It’s a wonderful way for Suneva to become fully capitalized to take advantage of the remarkable capabilities of the capital markets and to grow the business the way we intend to,” Altavilla said in an interview.</p><p>Suneva expects to grow by developing new products like a hair-restoration offering, acquiring businesses and catering to more men and millenials, she said.</p><p>Suneva specializes in so-called regenerative aesthetics that use the body’s own collagen to improve the skin’s appearance. Its biggest product is Bellafill, a Food and Drug Administration-approved dermal filler that is advertised to “smooth smile lines” and reduce the appearance of acne scars. Its products and procedures, all of which Altavilla said have a “biostimulatory component” are sold into medical offices and conducted by doctors, nurses or nurse practitioners. It has about 1600 customers, she said.</p><p>Viveon Health Acquisition, a special purpose acquisition company, or SPAC, raised $201 million in its initial public offering in 2020.</p><p>“People are looking toward more natural solutions,” Altavilla said. “The regenerative properties of these procedures allow them to have better longer-lasting results.”</p></body></html>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Aesthetics Firm Suneva Is in Talks for Viveon Health SPAC Deal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAesthetics Firm Suneva Is in Talks for Viveon Health SPAC Deal\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-12 22:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/aesthetics-firm-suneva-said-talks-010000738.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- Suneva Medical Inc., which sells beauty and anti-aging products to doctors’ offices, has agreed to go public through a merger with blank-check company Viveon Health Acquisition Corp.The...</p>\n\n<a href=\"https://finance.yahoo.com/news/aesthetics-firm-suneva-said-talks-010000738.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VHAQ":"Viveon Health Acquisition Corp"},"source_url":"https://finance.yahoo.com/news/aesthetics-firm-suneva-said-talks-010000738.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1199219279","content_text":"(Bloomberg) -- Suneva Medical Inc., which sells beauty and anti-aging products to doctors’ offices, has agreed to go public through a merger with blank-check company Viveon Health Acquisition Corp.The deal values the combined company at about $511 million including debt, according to a statement Wednesday that confirmed an earlier Bloomberg News report. Existing Suneva backers will invest $10 million in a private investment in public equity deal, according to Chief Executive Officer Pat Altavilla.The combined company will operate as Suneva Medical and trade on the New York Stock Exchange under the symbol RNEW, according to the statement.“It’s a wonderful way for Suneva to become fully capitalized to take advantage of the remarkable capabilities of the capital markets and to grow the business the way we intend to,” Altavilla said in an interview.Suneva expects to grow by developing new products like a hair-restoration offering, acquiring businesses and catering to more men and millenials, she said.Suneva specializes in so-called regenerative aesthetics that use the body’s own collagen to improve the skin’s appearance. Its biggest product is Bellafill, a Food and Drug Administration-approved dermal filler that is advertised to “smooth smile lines” and reduce the appearance of acne scars. Its products and procedures, all of which Altavilla said have a “biostimulatory component” are sold into medical offices and conducted by doctors, nurses or nurse practitioners. It has about 1600 customers, she said.Viveon Health Acquisition, a special purpose acquisition company, or SPAC, raised $201 million in its initial public offering in 2020.“People are looking toward more natural solutions,” Altavilla said. “The regenerative properties of these procedures allow them to have better longer-lasting results.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":1314,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":694127230,"gmtCreate":1641875151933,"gmtModify":1641875152131,"author":{"id":"3560092322694803","authorId":"3560092322694803","name":"dahae","avatar":"https://static.tigerbbs.com/137beae1f6048901843924ba46796740","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560092322694803","authorIdStr":"3560092322694803"},"themes":[],"htmlText":"Qqwq","listText":"Qqwq","text":"Qqwq","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/694127230","repostId":"1104925214","repostType":4,"repost":{"id":"1104925214","kind":"news","pubTimestamp":1641868694,"share":"https://www.laohunote.com/m/news/1104925214?lang=&edition=full","pubTime":"2022-01-11 10:38","market":"us","language":"en","title":"7 Hot Stocks to Buy on Any Dip This Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1104925214","media":"InvestorPlace","summary":"An increase in interest rates is looming due to higher inflation, supply-chain issues, lofty stock v","content":"<html><head></head><body><p>An increase in interest rates is looming due to higher inflation, supply-chain issues, lofty stock valuations and now the super-contagious omicron variant of Covid-19. As a result, forecasting market performance for 2022 seems more difficult than it’s been in previous years. Right now, it looks like the market is priced to perfection with a slim margin of error. Therefore, investors could benefit by keeping an eye on hot stocks.</p><p>Since March 2020, the bull market has seen returns of nearly 110% in the <b>S&amp;P 500</b>Index. Despite such a remarkable rally, we need to highlight that 93% of the index saw a selloff of more than 10% in 2021.</p><p>While Wells Fargo predicts that the S&amp;P 500 index could hit 5,300, Morgan Stanley has a bearish outlook with a year-end 2022 target for 4,400. That suggest a decline of more than 4% from current levels.</p><p>Amidst so much uncertainty, market analysts have expressed conflicting opinions about where investor gains in the new year may come from. Market forecasts for 2022 might ultimately rely on correctly forecasting how the pandemic evolves. “The pathof the economy continues to depend on the course of the virus,” the Federal Open Market Committee’s stated following the Federal Reserve meeting in December.</p><p>With that information, here are seven hot stocks that offer substantial upside to any investor portfolio in 2022:</p><ul><li><b>Analog Devices</b>(NASDAQ:<b>ADI</b>)</li><li><b>Applied Materials</b>(NASDAQ:<b>AMAT</b>)</li><li><b>Charles Schwab</b>(NYSE:<b>SCHW</b>)</li><li><b>Dupont De Nemours</b> (NYSE:<b>DD</b>)</li><li><b>Fisker</b> (NYSE:<b>FSR</b>)</li><li><b>Unity Software</b>(NYSE:<b>U</b>)</li><li><b>USCF Midstream Energy Income Fund</b>(NYSEARCA:<b>UMI</b>)</li></ul><p><b>Hot Stocks: Analog Devices</b>(ADI)</p><p><b>52-week range:</b>$142.25 – $191.95</p><p><b>Dividend yield:</b>1.6%</p><p>Leading our list of hot stocks to watch is Wilmington, Massachusetts-based Analog Devices. The company manufactures chips that leverage high-performance analog, mixed-signal and digital signal processing technology. The chipmaker has a leading market share in converter chips that translate analog signals to digital and vice versa.</p><p>Analog Devices announced fourth-quarter 2021 results on Nov. 23, 2021. Revenue increased 53% year-over-year (YOY) to $2.34 billion. Adjusted earnings increased from $1.44 per share to $1.73 per share. The chipmaker generated a free cash flow of $810 million during the period. Cash and equivalents ended the quarter at $1.98 billion.</p><p>On the metrics, CEO Vincent Roche said, “ADI delivered another quarter of record revenue and profits, marking a strong end to the fiscal year. Our Industrial and Automotive markets reached all-time highs and our Consumer business returned to solid growth in fiscal 2021.”</p><p>The chipmaker continues to expand its manufacturing capacity to meet the rising demand for its cutting-edge chips. In fact, Analog received more orders than it could fill during the past year, leading to a solid backlog for its products. Moreover, it has recently completed the acquisition of Maxim Integrated, further solidifying its position as a semiconductor leader.</p><p>Most of Analog’s revenue comes from the industrial and automotive markets. Factory automation is driving surging demand for sensors and connectivity options for machines, all of which require the use of ADI’s chips. Furthermore, the automotive industry’s demand for chips continues to grow rapidly due to the increasing popularity of electric vehicles(EVs).</p><p>Currently, ADI stock hovers just below $170 per share, up nearly 8% over the past 12 months. Shares are trading at 24 times forward earnings and 10 times trailing sales. The 12-month median price forecast for Analog Devicesstands at $210.</p><p><b>Applied Materials</b>(AMAT)</p><p><b>52-week range:</b>$94.18 – $163.02</p><p><b>Dividend yield:</b>0.6%</p><p>When it comes to semiconductor manufacturing equipment, the one company that tops the list is the Santa Clara, California-based Applied Materials. It iswell-known for materials and engineering solutions.</p><p>Applied Materials released Q4 2021 results in mid-November. It reported a record quarterly revenue of $6.12 billion, up 31% YOY. Adjusted net income came in at $1.76 billion, or $1.94 per diluted share, up 53% YOY from $1.15 billion, or $1.25 per diluted share, in the prior-year quarter.</p><p>“Applied delivered strong growth in fiscal 2021, with overall orders up by 62 percent year over year and Semiconductor Systems orders up 78 percent,” remarked CFO Bob Halliday. “The momentum continued as our Semiconductor Systems backlog increased during the fourth quarter from $5.5 billion to $6.7 billion, and we see this strength sustaining into 2022.”</p><p>The company stands to benefit from crucial high-growth trends, including artificial intelligence, 5G, cloud computing, the Internet of Things (IoT) and autonomous driving. In particular, Applied Materials continues to gain significant market share in process control, including wafer inspection and e-beam technology. Demand for these services should keep AMAT on your list of hot stocks to watch.</p><p>In addition, Applied Materials plays a vital role in the U.S. tech industry. The lion’s share of global chip manufacturing is based in Taiwan, so the U.S. and Europe are looking to expand their domestic chip manufacturing capabilities. This implies significant long-term growth opportunities for equipment suppliers like Applied Materials.</p><p>At present, AMAT stock is priced around $145. Over the past 12 months, it has surged 53%. Given the rising global demand for foundry and logic capacity, the company has a moderate valuation at 18.7 times forward earnings and 6.1 times trailing sales. The 12-month median price forecast for Applied Materials stock stands at $174.</p><p><b>Hot Stocks: Charles Schwab</b>(SCHW)</p><p><b>52-week range:</b>$50.77 – $92.32</p><p><b>Dividend yield:</b>0.8%</p><p>In addition to brokerage services, the San Francisco, California-based Charles Schwab offers asset management, wealth management, banking, and other financial advisory services. Currently,the group boasts about $8 trillion in client assets, nearly 33 million active brokerage accounts and more than 2 million corporate retirement plan participants.</p><p>Charles Schwab released Q3 2021 results in mid-October. Revenue surged 87% YOY to $4.57 billion. Further, adjusted net income grew 130% to $1.72 billion, or 84 cents per diluted share, up from $749 million, or 51 cents per diluted share, a year ago.</p><p>On the results, CEO Walt Bettinger remarked, “We generated core net new assets of $139.0 billion in the quarter, pushing asset gathering for the first nine months of the year to $396.0 billion, representing an 8% annualized organic growth rate. Total client assets ended September at $7.61 trillion, up from $6.69 trillion at year-end 2020.”</p><p>In 2021, the increase in assets contributed to high growth. Now Wall Street concurs that Schwab should benefit from rising interest rates in 2022. Net interest revenue accounted for around 45% of total revenue in Q3.</p><p>Considering the anticipated increase in interest rates and Schwab’s powerful organic growth potential, many investors are following SCHW stock closely. It currently hovers in $90 territory, and over the past 12 months, the stock price has jumped 54%. SCHW is trading at 23.3 times forward earnings and 8.5 times trailing sales. The 12-month median price forecast for Charles Schwab stock stands at $95.50.</p><p><b>Dupont De Nemours</b> (DD)</p><p><b>52-week range:</b>$66.37 – $87.27</p><p><b>Dividend yield:</b>1.44%</p><p>DuPont de Nemours is one of the largest chemical and specialty materials companies worldwide. It provides many synthetic components that serve automotive, electronics, construction, safety and water management industries.</p><p>The company released Q3 2021 results in early November. Revenue for the period totaled $4.3 billion, up 18% YOY. Net income stood at $391 million, or 75 cents per diluted share, compared to a net loss of $79 million, or a loss of 11 cents loss per diluted share, in the prior-year quarter. Dupont generated a free cash flow of $634 million during the quarter. Cash and equivalents ended the quarter at $1.67 billion.</p><p>DuPont is going through a transition period, shifting its focus from low-margin chemical businesses to higher-margin opportunities in sectors with long-term growth potential. In November, management announced the acquisitionof<b>Rogers Corporation</b> for $5.2 billion.</p><p>This acquisition allows DuPont to gain exposure to secular high-growth markets, including electric vehicles, 5G and clean energy. Meanwhile, DuPont plans to divest most of its Mobility &amp; Materials segment, including engineering polymers and performance resins products lines.</p><p>On the acquisition, CEO Ed Breen remarked, “Today we also separately announced a definitive agreement to acquire Rogers Corporation, an advanced materials provider with superior technology innovation, applications engineering expertise, and leading end-market positions.”</p><p>DD stock is currently priced just below $82 per share, up 2% in the past 12 months. Shares are trading at 16.5 times forward earnings and 2.2 times trailing sales. The 12-month median price forecast for DuPont stock stands at $96.</p><p><b>Hot Stocks: Fisker</b> (FSR)</p><p><b>52-week range:</b>$9.61 – $31.96</p><p>Manhattan Beach, California-based Fisker is a pre-revenue EV name that made its market debut in 2020. It has a unique asset-light business model based on contract manufacturing.</p><p>Fisker released Q3 2021 results in early November. Net loss for the period totaled $110 million, or a loss of 37 cents per share, compared to a net loss of $40 million in the previous year. Cash and equivalents ended the quarter at $1.4 billion.</p><p>After the announcement, CEO Henrik Fisker noted, “We continued to make rapid progress in Q3 2021 on our core focus, achieving program milestones that ensure we execute Fisker Ocean SUV on-time and with several segment-leading features.”</p><p>Production for the Fisker Ocean, a mid-size premium SUV, is set to begin in November. The EV will be available to consumers through a leasing package that costs $37,499, making it one of the most affordable EVs on the market. Fisker Ocean reservations are expected to increase in 2022 with the opening of experience centers.</p><p>The Ocean is sold exclusively through the Fisker app or website without a dealer network. As a result, Wall Street is interested in its low overhead costs. Further, contract manufacturing should allow the company to enhance its EV portfolio without investing in risky manufacturing capacity.</p><p>Understandably, without revenues, Fisker is a speculative EV play. FSR stock hovers in $15 territory, up 2% over the past year. The 12-month median price forecast for Fisker stock stands at $25.50.</p><p><b>Unity Software</b>(U)</p><p><b>52-week range:</b>$76 – $210</p><p>Unity Software offers a software platform for developing interactive experiences and creating computer-generated visuals. The company is well-known for providing an engine for video games that work across computers, consoles, smart phones and virtual reality (VR) devices.</p><p>Unity reported Q3 2021 results in early November. Revenue soared 43% YOY to $286 million. But non-GAAP loss widened to $12.1 million, or 6 cents per diluted share, compared to a loss of $8.4 million, or 9 cents per diluted share, in the previous year. Cash and equivalents ended the period at $755 million.</p><p>On the results, CEO John Riccitiello remarked, “Unity’s strong performance this quarter was driven by innovation in data science, vertical growth and making significant strides in bringing RT3D technologies and tools to as many creators and artists as possible.”</p><p>Wall Street agrees Unity should benefit from the development of the metaverse. It is swiftly gaining a solid foothold in the VR and augmented reality (AR) markets. Around 60% of all games built for AR and VR are currently utilizing its engine services.</p><p>Moreover, Unity has recently acquired the visual-effects studioWeta Digital. This new business could soon enable the company to offer digital-effects services for film, games and television.</p><p>Unity hit an all-time high of $210 in mid-November. However, it currently trades around $125, down 13% over the past year. Shares are trading at 39x trailing sales. The 12-month median price forecast for Unity stock stands at $185.</p><p><b>Hot Stocks: USCF Midstream Energy Income Fund</b>(UMI)</p><p><b>52-Week Range:</b> $24.32 – $32.62</p><p><b>Expense Ratio:</b> 0.85% per year</p><p>Closing out this list of hot stocks to monitor is the USCF Midstream Energy Income Fund, an exchange-traded fund (ETF).It invests in U.S. and Canadian midstream energy companies, including master limited partnerships (MLPs). These energy infrastructure companies focus on transportation, storage, gathering and processing of energy.</p><p>UMI, which started trading in March 2021, has24 holdings. Fund managers choose companies based on their income growth, balance sheet strength, distribution (or dividend) coverage and contract quality. Exposure to commodity prices is also important as it can impact share prices, especially in the short run.</p><p>The top 10 names account for around 65% of net assets of $125.2 million. Among the leading names on the roster are <b>Targa Resources</b>(NYSE:<b><u>TRGP</u></b>),<b>Enbridge</b>(NYSE:<b><u>ENB</u></b>) and <b>Enterprise Products Partners</b>(NYSE:<b><u>EPD</u></b>).</p><p>Robust MLPs with quality contracts and solid fundamental metrics tend to be cash cows that most investors love. Since its inception in March 2020, UMI has soared more than 20% and saw a record high of $32.62 in mid-October. Interested investors should consider buying at $28.50.</p></body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Hot Stocks to Buy on Any Dip This Year</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Hot Stocks to Buy on Any Dip This Year\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-11 10:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/01/7-hot-stocks-to-buy-on-any-dip-this-year/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>An increase in interest rates is looming due to higher inflation, supply-chain issues, lofty stock valuations and now the super-contagious omicron variant of Covid-19. As a result, forecasting market ...</p>\n\n<a href=\"https://investorplace.com/2022/01/7-hot-stocks-to-buy-on-any-dip-this-year/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ADMT":"ADM Tronics Unlimited, Inc.","FSR":"菲斯克","U":"Unity Software Inc.","SCHW":"嘉信理财","UMI":"USCF Midstream Energy Income Fund","ADI":"亚德诺","DD":"杜邦"},"source_url":"https://investorplace.com/2022/01/7-hot-stocks-to-buy-on-any-dip-this-year/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1104925214","content_text":"An increase in interest rates is looming due to higher inflation, supply-chain issues, lofty stock valuations and now the super-contagious omicron variant of Covid-19. As a result, forecasting market performance for 2022 seems more difficult than it’s been in previous years. Right now, it looks like the market is priced to perfection with a slim margin of error. Therefore, investors could benefit by keeping an eye on hot stocks.Since March 2020, the bull market has seen returns of nearly 110% in the S&P 500Index. Despite such a remarkable rally, we need to highlight that 93% of the index saw a selloff of more than 10% in 2021.While Wells Fargo predicts that the S&P 500 index could hit 5,300, Morgan Stanley has a bearish outlook with a year-end 2022 target for 4,400. That suggest a decline of more than 4% from current levels.Amidst so much uncertainty, market analysts have expressed conflicting opinions about where investor gains in the new year may come from. Market forecasts for 2022 might ultimately rely on correctly forecasting how the pandemic evolves. “The pathof the economy continues to depend on the course of the virus,” the Federal Open Market Committee’s stated following the Federal Reserve meeting in December.With that information, here are seven hot stocks that offer substantial upside to any investor portfolio in 2022:Analog Devices(NASDAQ:ADI)Applied Materials(NASDAQ:AMAT)Charles Schwab(NYSE:SCHW)Dupont De Nemours (NYSE:DD)Fisker (NYSE:FSR)Unity Software(NYSE:U)USCF Midstream Energy Income Fund(NYSEARCA:UMI)Hot Stocks: Analog Devices(ADI)52-week range:$142.25 – $191.95Dividend yield:1.6%Leading our list of hot stocks to watch is Wilmington, Massachusetts-based Analog Devices. The company manufactures chips that leverage high-performance analog, mixed-signal and digital signal processing technology. The chipmaker has a leading market share in converter chips that translate analog signals to digital and vice versa.Analog Devices announced fourth-quarter 2021 results on Nov. 23, 2021. Revenue increased 53% year-over-year (YOY) to $2.34 billion. Adjusted earnings increased from $1.44 per share to $1.73 per share. The chipmaker generated a free cash flow of $810 million during the period. Cash and equivalents ended the quarter at $1.98 billion.On the metrics, CEO Vincent Roche said, “ADI delivered another quarter of record revenue and profits, marking a strong end to the fiscal year. Our Industrial and Automotive markets reached all-time highs and our Consumer business returned to solid growth in fiscal 2021.”The chipmaker continues to expand its manufacturing capacity to meet the rising demand for its cutting-edge chips. In fact, Analog received more orders than it could fill during the past year, leading to a solid backlog for its products. Moreover, it has recently completed the acquisition of Maxim Integrated, further solidifying its position as a semiconductor leader.Most of Analog’s revenue comes from the industrial and automotive markets. Factory automation is driving surging demand for sensors and connectivity options for machines, all of which require the use of ADI’s chips. Furthermore, the automotive industry’s demand for chips continues to grow rapidly due to the increasing popularity of electric vehicles(EVs).Currently, ADI stock hovers just below $170 per share, up nearly 8% over the past 12 months. Shares are trading at 24 times forward earnings and 10 times trailing sales. The 12-month median price forecast for Analog Devicesstands at $210.Applied Materials(AMAT)52-week range:$94.18 – $163.02Dividend yield:0.6%When it comes to semiconductor manufacturing equipment, the one company that tops the list is the Santa Clara, California-based Applied Materials. It iswell-known for materials and engineering solutions.Applied Materials released Q4 2021 results in mid-November. It reported a record quarterly revenue of $6.12 billion, up 31% YOY. Adjusted net income came in at $1.76 billion, or $1.94 per diluted share, up 53% YOY from $1.15 billion, or $1.25 per diluted share, in the prior-year quarter.“Applied delivered strong growth in fiscal 2021, with overall orders up by 62 percent year over year and Semiconductor Systems orders up 78 percent,” remarked CFO Bob Halliday. “The momentum continued as our Semiconductor Systems backlog increased during the fourth quarter from $5.5 billion to $6.7 billion, and we see this strength sustaining into 2022.”The company stands to benefit from crucial high-growth trends, including artificial intelligence, 5G, cloud computing, the Internet of Things (IoT) and autonomous driving. In particular, Applied Materials continues to gain significant market share in process control, including wafer inspection and e-beam technology. Demand for these services should keep AMAT on your list of hot stocks to watch.In addition, Applied Materials plays a vital role in the U.S. tech industry. The lion’s share of global chip manufacturing is based in Taiwan, so the U.S. and Europe are looking to expand their domestic chip manufacturing capabilities. This implies significant long-term growth opportunities for equipment suppliers like Applied Materials.At present, AMAT stock is priced around $145. Over the past 12 months, it has surged 53%. Given the rising global demand for foundry and logic capacity, the company has a moderate valuation at 18.7 times forward earnings and 6.1 times trailing sales. The 12-month median price forecast for Applied Materials stock stands at $174.Hot Stocks: Charles Schwab(SCHW)52-week range:$50.77 – $92.32Dividend yield:0.8%In addition to brokerage services, the San Francisco, California-based Charles Schwab offers asset management, wealth management, banking, and other financial advisory services. Currently,the group boasts about $8 trillion in client assets, nearly 33 million active brokerage accounts and more than 2 million corporate retirement plan participants.Charles Schwab released Q3 2021 results in mid-October. Revenue surged 87% YOY to $4.57 billion. Further, adjusted net income grew 130% to $1.72 billion, or 84 cents per diluted share, up from $749 million, or 51 cents per diluted share, a year ago.On the results, CEO Walt Bettinger remarked, “We generated core net new assets of $139.0 billion in the quarter, pushing asset gathering for the first nine months of the year to $396.0 billion, representing an 8% annualized organic growth rate. Total client assets ended September at $7.61 trillion, up from $6.69 trillion at year-end 2020.”In 2021, the increase in assets contributed to high growth. Now Wall Street concurs that Schwab should benefit from rising interest rates in 2022. Net interest revenue accounted for around 45% of total revenue in Q3.Considering the anticipated increase in interest rates and Schwab’s powerful organic growth potential, many investors are following SCHW stock closely. It currently hovers in $90 territory, and over the past 12 months, the stock price has jumped 54%. SCHW is trading at 23.3 times forward earnings and 8.5 times trailing sales. The 12-month median price forecast for Charles Schwab stock stands at $95.50.Dupont De Nemours (DD)52-week range:$66.37 – $87.27Dividend yield:1.44%DuPont de Nemours is one of the largest chemical and specialty materials companies worldwide. It provides many synthetic components that serve automotive, electronics, construction, safety and water management industries.The company released Q3 2021 results in early November. Revenue for the period totaled $4.3 billion, up 18% YOY. Net income stood at $391 million, or 75 cents per diluted share, compared to a net loss of $79 million, or a loss of 11 cents loss per diluted share, in the prior-year quarter. Dupont generated a free cash flow of $634 million during the quarter. Cash and equivalents ended the quarter at $1.67 billion.DuPont is going through a transition period, shifting its focus from low-margin chemical businesses to higher-margin opportunities in sectors with long-term growth potential. In November, management announced the acquisitionofRogers Corporation for $5.2 billion.This acquisition allows DuPont to gain exposure to secular high-growth markets, including electric vehicles, 5G and clean energy. Meanwhile, DuPont plans to divest most of its Mobility & Materials segment, including engineering polymers and performance resins products lines.On the acquisition, CEO Ed Breen remarked, “Today we also separately announced a definitive agreement to acquire Rogers Corporation, an advanced materials provider with superior technology innovation, applications engineering expertise, and leading end-market positions.”DD stock is currently priced just below $82 per share, up 2% in the past 12 months. Shares are trading at 16.5 times forward earnings and 2.2 times trailing sales. The 12-month median price forecast for DuPont stock stands at $96.Hot Stocks: Fisker (FSR)52-week range:$9.61 – $31.96Manhattan Beach, California-based Fisker is a pre-revenue EV name that made its market debut in 2020. It has a unique asset-light business model based on contract manufacturing.Fisker released Q3 2021 results in early November. Net loss for the period totaled $110 million, or a loss of 37 cents per share, compared to a net loss of $40 million in the previous year. Cash and equivalents ended the quarter at $1.4 billion.After the announcement, CEO Henrik Fisker noted, “We continued to make rapid progress in Q3 2021 on our core focus, achieving program milestones that ensure we execute Fisker Ocean SUV on-time and with several segment-leading features.”Production for the Fisker Ocean, a mid-size premium SUV, is set to begin in November. The EV will be available to consumers through a leasing package that costs $37,499, making it one of the most affordable EVs on the market. Fisker Ocean reservations are expected to increase in 2022 with the opening of experience centers.The Ocean is sold exclusively through the Fisker app or website without a dealer network. As a result, Wall Street is interested in its low overhead costs. Further, contract manufacturing should allow the company to enhance its EV portfolio without investing in risky manufacturing capacity.Understandably, without revenues, Fisker is a speculative EV play. FSR stock hovers in $15 territory, up 2% over the past year. The 12-month median price forecast for Fisker stock stands at $25.50.Unity Software(U)52-week range:$76 – $210Unity Software offers a software platform for developing interactive experiences and creating computer-generated visuals. The company is well-known for providing an engine for video games that work across computers, consoles, smart phones and virtual reality (VR) devices.Unity reported Q3 2021 results in early November. Revenue soared 43% YOY to $286 million. But non-GAAP loss widened to $12.1 million, or 6 cents per diluted share, compared to a loss of $8.4 million, or 9 cents per diluted share, in the previous year. Cash and equivalents ended the period at $755 million.On the results, CEO John Riccitiello remarked, “Unity’s strong performance this quarter was driven by innovation in data science, vertical growth and making significant strides in bringing RT3D technologies and tools to as many creators and artists as possible.”Wall Street agrees Unity should benefit from the development of the metaverse. It is swiftly gaining a solid foothold in the VR and augmented reality (AR) markets. Around 60% of all games built for AR and VR are currently utilizing its engine services.Moreover, Unity has recently acquired the visual-effects studioWeta Digital. This new business could soon enable the company to offer digital-effects services for film, games and television.Unity hit an all-time high of $210 in mid-November. However, it currently trades around $125, down 13% over the past year. Shares are trading at 39x trailing sales. The 12-month median price forecast for Unity stock stands at $185.Hot Stocks: USCF Midstream Energy Income Fund(UMI)52-Week Range: $24.32 – $32.62Expense Ratio: 0.85% per yearClosing out this list of hot stocks to monitor is the USCF Midstream Energy Income Fund, an exchange-traded fund (ETF).It invests in U.S. and Canadian midstream energy companies, including master limited partnerships (MLPs). These energy infrastructure companies focus on transportation, storage, gathering and processing of energy.UMI, which started trading in March 2021, has24 holdings. Fund managers choose companies based on their income growth, balance sheet strength, distribution (or dividend) coverage and contract quality. Exposure to commodity prices is also important as it can impact share prices, especially in the short run.The top 10 names account for around 65% of net assets of $125.2 million. Among the leading names on the roster are Targa Resources(NYSE:TRGP),Enbridge(NYSE:ENB) and Enterprise Products Partners(NYSE:EPD).Robust MLPs with quality contracts and solid fundamental metrics tend to be cash cows that most investors love. Since its inception in March 2020, UMI has soared more than 20% and saw a record high of $32.62 in mid-October. Interested investors should consider buying at $28.50.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1093,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":694391913,"gmtCreate":1641806328163,"gmtModify":1641806328363,"author":{"id":"3560092322694803","authorId":"3560092322694803","name":"dahae","avatar":"https://static.tigerbbs.com/137beae1f6048901843924ba46796740","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560092322694803","authorIdStr":"3560092322694803"},"themes":[],"htmlText":"Qqqqq","listText":"Qqqqq","text":"Qqqqq","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/694391913","repostId":"1199490797","repostType":4,"repost":{"id":"1199490797","kind":"news","pubTimestamp":1641828722,"share":"https://www.laohunote.com/m/news/1199490797?lang=&edition=full","pubTime":"2022-01-10 23:32","market":"us","language":"en","title":"Is Tesla Stock Headed to $1,400 or $67? Why Predicting Auto Makers’ Performance Is Tricky","url":"https://stock-news.laohu8.com/highlight/detail?id=1199490797","media":"Barrons","summary":"Who needs parody cryptocurrency when car stocks are this exciting?","content":"<html><head></head><body><p>Who needs parody cryptocurrency when car stocks are this exciting? Ford Motor, General Motors, Tesla, and Rivian Automotive each had price swings of more than 10% during the first trading week of the year. This, after some heady gains for the group last year.</p><p>Predicting performance from here won’t be easy. I recently spoke with one analyst who says Tesla stock (ticker: TSLA) is headed to $1,400, and another who says $67. You know what they say: Sometimes you have to agree to disagree by a factor of 20.</p><p>Tesla made the first big move, jumping 13.5% on Monday after the company reported fourth-quarter deliveries of 308,600 vehicles, trouncing estimates and its own record. Next, Ford (F) gained 11.7% on Tuesday after it announced that it would raise production of its first electric pickup, the F-150 Lightning, to 150,000 units a year.</p><p>By that point in the week, General Motors stock (GM) was already up 12% in anticipation of its Chevy Silverado electric pickup truck unveiling, planned for Wednesday at the Consumer Electronics Show. But on the day of the announcement, shares slipped. Maybe investors were disappointed in the delivery timing, or maybe it was because the broad market tanked on signs that interest rates could rise sooner than expected.</p><p>What the Ford and Chevy pickups have in common is that they will target workers as well as suburban preeners in unblemished Carhartt jackets. Early versions will be priced around $40,000 and $100,000.</p><p>The Chevy wins on electric specs—longer battery range and faster charging. But Ford wins on bringing its truck to market this spring. Chevy buyers will have to wait until spring 2023 for the cheaper truck and fall 2023 for the decked-out one. GM will also debut electric Chevy sport utility vehicles in 2023, including an Equinox that will start at $30,000.</p><p>Pickup trucks could be the key to America’s electric-vehicle uptake. Last year, EVs hit an estimated 4% of total U.S. sales, up from 2%. But Europe and China are well ahead, with penetration rates in the low teens. Americans have so far had few electric choices for the types of vehicles they like to buy. Last year, the Ford F-150 led U.S. new-vehicle sales, as always. The only surprise was that the Ram 1500 pickup pulled ahead of the Chevy Silverado 1500 to be No. 2.</p><p>An electric Ram will take until 2024, according to owner Stellantis (STLA), a roll-up of American, Italian, and French brands. Start-up Rivian (RIVN) says it will ship electric pickups this year, but that stock slid 11% this past Wednesday after early backer Amazon.com (AMZN) said it’s putting in an order with Ram for delivery trucks. Tesla’s Cybertruck was expected last year, but has been delayed.</p><p>Pent-up vehicle demand, meanwhile, suggests that a boom is coming. Amid shortages last year, U.S. light-vehicle sales were an estimated 15.1 million units, versus closer to 17 million a year before the pandemic. Average transaction prices have soared 30% from prepandemic levels, and incentives as a percentage of prices are at record lows.</p><p>This year, expect unit sales to rise only modestly, but by next year, when showrooms are full and pricing has eased, units could jump to 18 million, Credit Suisse says. EV penetration in the U.S. will double again this year to 8%, and top 50% by 2030, it adds.</p><p>One risk for legacy car makers is that they will run to stand still—that they must ramp up EV units with low profit margins for now to offset coming losses in high-margin gasoline models.</p><p>On the other hand, car makers could shift capacity from gasoline vehicles to electric ones ahead of customers’ willingness to make the switch. That could leave gas vehicles with high prices and profit margins, creating a long, lucrative “farewell tour,” as Morgan Stanley analyst Adam Jonas puts it.</p><p>Valuations appear undemanding. Ford goes for 12 times projected earnings, despite doubling in price last year. GM sells for nine times.</p><p>The bull case on Tesla is that it will do big things in both cars and adjacent markets. Philippe Houchois, who covers the stock for Jefferies, sees 35% upside from recent levels, to $1,400. Tesla lags behind legacy rivals on things like build quality and finish, but those are solvable problems, he says. It leads on software, batteries, and autonomy, which are durable advantages. He sees Tesla using software to extend the usefulness and profit potential of vehicles.</p><p>Most versions of the Tesla bear case assume that the company will do well in cars, but not well enough to justify a market value above $1 trillion. For example, J.P. Morgan’s Ryan Brinkman calls his price target of $295 “not ungenerous,” even though it implies a 70% stock plunge, because it values Tesla slightly ahead of world leader Toyota Motor (TM), despite producing a tenth as many cars for now.</p><p>Then there’s Gordon Johnson. He worked at large investment banks before starting GLJ Research, where he covers 20 stocks. He’s bullish on uranium stocks and bearish on cannabis, but all anyone wants to talk about, he says, is his $67 price target on Tesla. “I’ve gotten death threats,” he says. “Now I don’t even answer the phone when I have unknown calls.”</p><p>In Johnson’s view, there’s no reason to assume Tesla will do well in adjacent businesses. “You could take McDonald’s and say they’re going to start selling Nikes and chairs and pianos and add those valuations,” he says. In cars, he calculates that the stock price implies a production ramp-up that no car maker could achieve. “Selling cars is not selling iPhones or shirts,” he says.</p><p>If Tesla’s three-year stock gain of nearly 1,400% has shaken Johnson’s confidence, it doesn’t show. After walking me through his valuation model, he said he’s concerned that his price target might be too high.</p></body></html>","source":"market_watch","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Tesla Stock Headed to $1,400 or $67? Why Predicting Auto Makers’ Performance Is Tricky</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Tesla Stock Headed to $1,400 or $67? Why Predicting Auto Makers’ Performance Is Tricky\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-10 23:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/articles/tesla-ford-rivian-gm-stock-51641597012?mod=mw_quote_news><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Who needs parody cryptocurrency when car stocks are this exciting? Ford Motor, General Motors, Tesla, and Rivian Automotive each had price swings of more than 10% during the first trading week of the ...</p>\n\n<a href=\"https://www.marketwatch.com/articles/tesla-ford-rivian-gm-stock-51641597012?mod=mw_quote_news\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GM":"通用汽车","RIVN":"Rivian Automotive, Inc.","F":"福特汽车","TSLA":"特斯拉"},"source_url":"https://www.marketwatch.com/articles/tesla-ford-rivian-gm-stock-51641597012?mod=mw_quote_news","is_english":true,"share_image_url":"https://static.laohu8.com/599a65733b8245fcf7868668ef9ad712","article_id":"1199490797","content_text":"Who needs parody cryptocurrency when car stocks are this exciting? Ford Motor, General Motors, Tesla, and Rivian Automotive each had price swings of more than 10% during the first trading week of the year. This, after some heady gains for the group last year.Predicting performance from here won’t be easy. I recently spoke with one analyst who says Tesla stock (ticker: TSLA) is headed to $1,400, and another who says $67. You know what they say: Sometimes you have to agree to disagree by a factor of 20.Tesla made the first big move, jumping 13.5% on Monday after the company reported fourth-quarter deliveries of 308,600 vehicles, trouncing estimates and its own record. Next, Ford (F) gained 11.7% on Tuesday after it announced that it would raise production of its first electric pickup, the F-150 Lightning, to 150,000 units a year.By that point in the week, General Motors stock (GM) was already up 12% in anticipation of its Chevy Silverado electric pickup truck unveiling, planned for Wednesday at the Consumer Electronics Show. But on the day of the announcement, shares slipped. Maybe investors were disappointed in the delivery timing, or maybe it was because the broad market tanked on signs that interest rates could rise sooner than expected.What the Ford and Chevy pickups have in common is that they will target workers as well as suburban preeners in unblemished Carhartt jackets. Early versions will be priced around $40,000 and $100,000.The Chevy wins on electric specs—longer battery range and faster charging. But Ford wins on bringing its truck to market this spring. Chevy buyers will have to wait until spring 2023 for the cheaper truck and fall 2023 for the decked-out one. GM will also debut electric Chevy sport utility vehicles in 2023, including an Equinox that will start at $30,000.Pickup trucks could be the key to America’s electric-vehicle uptake. Last year, EVs hit an estimated 4% of total U.S. sales, up from 2%. But Europe and China are well ahead, with penetration rates in the low teens. Americans have so far had few electric choices for the types of vehicles they like to buy. Last year, the Ford F-150 led U.S. new-vehicle sales, as always. The only surprise was that the Ram 1500 pickup pulled ahead of the Chevy Silverado 1500 to be No. 2.An electric Ram will take until 2024, according to owner Stellantis (STLA), a roll-up of American, Italian, and French brands. Start-up Rivian (RIVN) says it will ship electric pickups this year, but that stock slid 11% this past Wednesday after early backer Amazon.com (AMZN) said it’s putting in an order with Ram for delivery trucks. Tesla’s Cybertruck was expected last year, but has been delayed.Pent-up vehicle demand, meanwhile, suggests that a boom is coming. Amid shortages last year, U.S. light-vehicle sales were an estimated 15.1 million units, versus closer to 17 million a year before the pandemic. Average transaction prices have soared 30% from prepandemic levels, and incentives as a percentage of prices are at record lows.This year, expect unit sales to rise only modestly, but by next year, when showrooms are full and pricing has eased, units could jump to 18 million, Credit Suisse says. EV penetration in the U.S. will double again this year to 8%, and top 50% by 2030, it adds.One risk for legacy car makers is that they will run to stand still—that they must ramp up EV units with low profit margins for now to offset coming losses in high-margin gasoline models.On the other hand, car makers could shift capacity from gasoline vehicles to electric ones ahead of customers’ willingness to make the switch. That could leave gas vehicles with high prices and profit margins, creating a long, lucrative “farewell tour,” as Morgan Stanley analyst Adam Jonas puts it.Valuations appear undemanding. Ford goes for 12 times projected earnings, despite doubling in price last year. GM sells for nine times.The bull case on Tesla is that it will do big things in both cars and adjacent markets. Philippe Houchois, who covers the stock for Jefferies, sees 35% upside from recent levels, to $1,400. Tesla lags behind legacy rivals on things like build quality and finish, but those are solvable problems, he says. It leads on software, batteries, and autonomy, which are durable advantages. He sees Tesla using software to extend the usefulness and profit potential of vehicles.Most versions of the Tesla bear case assume that the company will do well in cars, but not well enough to justify a market value above $1 trillion. For example, J.P. Morgan’s Ryan Brinkman calls his price target of $295 “not ungenerous,” even though it implies a 70% stock plunge, because it values Tesla slightly ahead of world leader Toyota Motor (TM), despite producing a tenth as many cars for now.Then there’s Gordon Johnson. He worked at large investment banks before starting GLJ Research, where he covers 20 stocks. He’s bullish on uranium stocks and bearish on cannabis, but all anyone wants to talk about, he says, is his $67 price target on Tesla. “I’ve gotten death threats,” he says. “Now I don’t even answer the phone when I have unknown calls.”In Johnson’s view, there’s no reason to assume Tesla will do well in adjacent businesses. “You could take McDonald’s and say they’re going to start selling Nikes and chairs and pianos and add those valuations,” he says. In cars, he calculates that the stock price implies a production ramp-up that no car maker could achieve. “Selling cars is not selling iPhones or shirts,” he says.If Tesla’s three-year stock gain of nearly 1,400% has shaken Johnson’s confidence, it doesn’t show. After walking me through his valuation model, he said he’s concerned that his price target might be too high.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1711,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":694043617,"gmtCreate":1641744434029,"gmtModify":1641744434241,"author":{"id":"3560092322694803","authorId":"3560092322694803","name":"dahae","avatar":"https://static.tigerbbs.com/137beae1f6048901843924ba46796740","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560092322694803","authorIdStr":"3560092322694803"},"themes":[],"htmlText":"Qqqq","listText":"Qqqq","text":"Qqqq","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/694043617","repostId":"1129882080","repostType":4,"repost":{"id":"1129882080","kind":"news","pubTimestamp":1641605937,"share":"https://www.laohunote.com/m/news/1129882080?lang=&edition=full","pubTime":"2022-01-08 09:38","market":"us","language":"en","title":"The Year’s First Three IPOs All Struggled. This Is Why.","url":"https://stock-news.laohu8.com/highlight/detail?id=1129882080","media":"Barrons","summary":"The first initial public offerings of 2022, a trio of biotech companies, went public with dismal res","content":"<html><head></head><body><p>The first initial public offerings of 2022, a trio of biotech companies, went public with dismal results.</p><p>Amylyx Pharmaceuticals,and Vigil Neuroscience both dropped below their issue prices while CinCor Pharma ended flat. The lackluster debuts signal that the IPO market has yet to recover from 2021’s downturn.</p><p>The three are the first to trade since new issues went on pause in December. After a rousing 11 months in 2021, where IPOs delivered their best year ever, inflation and Omicron issues slowed offerings in December. Only a dozen companies went public that month using a traditional IPO, down from 34 in November and 39 in October.</p><p>Biotechs are less sensitive to overall market trends, said Matt Kennedy, senior IPO strategist at Renaissance Capital, enabling them to go ahead while other firms have not.</p><p>The muted first day for Friday’s trio is a continuation of 2021’s dismal IPO returns, he said. Of the 397 companies that went public in 2021 using a traditional IPO, roughly 31%, or 121, are trading above their offer price, he said. This means 69% are below their IPO price.</p><p>The performance of 2021’s class of biotechs is worse. Of the 94 companies that listed last year, only 15 are trading above their issue price, Kennedy said. Some investors are still “holding out hope for a pop,” he said, but there isn’t much demand for new deals right now. “There’s only so long that goes on before initial investors stop showing up, and then we may see a pause in activity,” he said.</p><p>A key pointmay come next week, when two high-profile deals are set to open. TPG,a large private-equity firm, and Justworks, an HR software company, are both scheduled to trade. If the companies end up slashing their price ranges, that would indicate the IPO market is challenging even for profitable companies, Kennedy said. “You don’t come off a year like 2021 and get back to normal in just a few weeks. We need to see [recent IPOs] returns improve before we can expect normal deal flow,” he  said.</p><p>Cincor (ticker:CINC), which is developing therapies to treat hypertension and other cardio-renal diseases, was the first to open Friday. Cincor raised nearly $194 million after selling 12.1 million shares at $16. It had filed to offer 11 million shares priced at $15 to $17. Shares kicked off at $21 and dropped, frequently trading above and below the $16 IPO price before closing at that level.</p><p>Shares of Amylyx (AMLX), meanwhile, kicked off at $21 and ended the day at $18.07, nearly 5% below its issue price. Amylyx is focused on therapies to treat ALS and other neurodegenerative diseases. Amylyx, which also boosted the size of its deal,raised $190 million after selling 10 million shares priced at $19 each. It had planned on offering 8.75 million at $18 to $20.</p><p>Vigil (VIGL), which aims to provide treatments for neurodegenerative diseases,collected $98 million after selling 7 million shares at $14, below its $15-to-$17 price range. Vigil opened at $12, below its IPO price, and closed down nearly 10% to $12.65.</p><p>Jordan Stuart, a market strategist for the Federated Hermes Kaufmann funds that focus on small-, mid-, and large-cap companies and invests in IPOs, has one word of advice for investors: patience.</p><p>Many biotechs went public in 2021 at a very early stage and it may make sense to wait for a “timing catalyst” before investing, Stuart said. He pointed to Federated’s experience with Moderna(MRNA), which went public in 2018. Federated passed on buying into the IPO “because there was nothing urgent” to prompt their investment, Stuart said.</p><p>But in January 2020, the Centers for Disease Control and Prevention, or CDC, detected the first U.S. case of Covid-19, and by March, businesses across the nation were closing in an attempt to stop the spread of the virus. Federated invested in Moderna in the first quarter of 2020 at around $30 a share, Stuart said.</p><p>The biotech’s Covid-19 vaccine received emergency-use authorization by the FDA later that year, in December. Moderna’s stock hit a high of $384.86 in September and is now trading at $213.58. Federated, across its funds, owned a significant stake in Moderna as of Sept. 30, Stuart said.</p><p>While the investment manager may have left some money on the table by waiting, Stuart estimates that Federated has made from five to 10 times its money with its Moderna investment. “It’s good that companies are coming out very early. But given the heat of last year’s IPO market, patience can be a virtue,” he said.</p></body></html>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The Year’s First Three IPOs All Struggled. This Is Why.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe Year’s First Three IPOs All Struggled. This Is Why.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-08 09:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/2022-ipos-fall-weak-51641580444?mod=hp_LATEST><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The first initial public offerings of 2022, a trio of biotech companies, went public with dismal results.Amylyx Pharmaceuticals,and Vigil Neuroscience both dropped below their issue prices while ...</p>\n\n<a href=\"https://www.barrons.com/articles/2022-ipos-fall-weak-51641580444?mod=hp_LATEST\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMLX":"Amylyx Pharmaceuticals","CINC":"CinCor Pharma, Inc.","VIGL":"Vigil Neuroscience, Inc."},"source_url":"https://www.barrons.com/articles/2022-ipos-fall-weak-51641580444?mod=hp_LATEST","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1129882080","content_text":"The first initial public offerings of 2022, a trio of biotech companies, went public with dismal results.Amylyx Pharmaceuticals,and Vigil Neuroscience both dropped below their issue prices while CinCor Pharma ended flat. The lackluster debuts signal that the IPO market has yet to recover from 2021’s downturn.The three are the first to trade since new issues went on pause in December. After a rousing 11 months in 2021, where IPOs delivered their best year ever, inflation and Omicron issues slowed offerings in December. Only a dozen companies went public that month using a traditional IPO, down from 34 in November and 39 in October.Biotechs are less sensitive to overall market trends, said Matt Kennedy, senior IPO strategist at Renaissance Capital, enabling them to go ahead while other firms have not.The muted first day for Friday’s trio is a continuation of 2021’s dismal IPO returns, he said. Of the 397 companies that went public in 2021 using a traditional IPO, roughly 31%, or 121, are trading above their offer price, he said. This means 69% are below their IPO price.The performance of 2021’s class of biotechs is worse. Of the 94 companies that listed last year, only 15 are trading above their issue price, Kennedy said. Some investors are still “holding out hope for a pop,” he said, but there isn’t much demand for new deals right now. “There’s only so long that goes on before initial investors stop showing up, and then we may see a pause in activity,” he said.A key pointmay come next week, when two high-profile deals are set to open. TPG,a large private-equity firm, and Justworks, an HR software company, are both scheduled to trade. If the companies end up slashing their price ranges, that would indicate the IPO market is challenging even for profitable companies, Kennedy said. “You don’t come off a year like 2021 and get back to normal in just a few weeks. We need to see [recent IPOs] returns improve before we can expect normal deal flow,” he  said.Cincor (ticker:CINC), which is developing therapies to treat hypertension and other cardio-renal diseases, was the first to open Friday. Cincor raised nearly $194 million after selling 12.1 million shares at $16. It had filed to offer 11 million shares priced at $15 to $17. Shares kicked off at $21 and dropped, frequently trading above and below the $16 IPO price before closing at that level.Shares of Amylyx (AMLX), meanwhile, kicked off at $21 and ended the day at $18.07, nearly 5% below its issue price. Amylyx is focused on therapies to treat ALS and other neurodegenerative diseases. Amylyx, which also boosted the size of its deal,raised $190 million after selling 10 million shares priced at $19 each. It had planned on offering 8.75 million at $18 to $20.Vigil (VIGL), which aims to provide treatments for neurodegenerative diseases,collected $98 million after selling 7 million shares at $14, below its $15-to-$17 price range. Vigil opened at $12, below its IPO price, and closed down nearly 10% to $12.65.Jordan Stuart, a market strategist for the Federated Hermes Kaufmann funds that focus on small-, mid-, and large-cap companies and invests in IPOs, has one word of advice for investors: patience.Many biotechs went public in 2021 at a very early stage and it may make sense to wait for a “timing catalyst” before investing, Stuart said. He pointed to Federated’s experience with Moderna(MRNA), which went public in 2018. Federated passed on buying into the IPO “because there was nothing urgent” to prompt their investment, Stuart said.But in January 2020, the Centers for Disease Control and Prevention, or CDC, detected the first U.S. case of Covid-19, and by March, businesses across the nation were closing in an attempt to stop the spread of the virus. Federated invested in Moderna in the first quarter of 2020 at around $30 a share, Stuart said.The biotech’s Covid-19 vaccine received emergency-use authorization by the FDA later that year, in December. Moderna’s stock hit a high of $384.86 in September and is now trading at $213.58. Federated, across its funds, owned a significant stake in Moderna as of Sept. 30, Stuart said.While the investment manager may have left some money on the table by waiting, Stuart estimates that Federated has made from five to 10 times its money with its Moderna investment. “It’s good that companies are coming out very early. But given the heat of last year’s IPO market, patience can be a virtue,” he said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1238,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":695775599,"gmtCreate":1641639144236,"gmtModify":1641639144846,"author":{"id":"3560092322694803","authorId":"3560092322694803","name":"dahae","avatar":"https://static.tigerbbs.com/137beae1f6048901843924ba46796740","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560092322694803","authorIdStr":"3560092322694803"},"themes":[],"htmlText":"Qqq","listText":"Qqq","text":"Qqq","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/695775599","repostId":"2201243576","repostType":4,"isVote":1,"tweetType":1,"viewCount":1064,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"posts","isTTM":false}